Revenue
2011
2012
2013
2014
2015
2016
2023
2024
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | — | — | — | — | — | — | $3,658 | $3,658 | $5,931 | $11,862 | $0 | $0 |
| Research & development | $21,671 | $23,416 | $82,759 | $200,691 | $748,545 | $1.1M | $520,084 | $1.2M | $425,983 | $348,559 | $520,462 | $134,862 | $191,709 | $161,541 | $636,620 |
| Operating expenses | $2.2M | $2.1M | $3.2M | $2.6M | $2.8M | $4.2M | $2.2M | $3.5M | $2.1M | $4.1M | $5.3M | $5.4M | $8.0M | $6.5M | $7.0M |
| Operating income | −$2.2M | −$2.1M | −$3.2M | −$2.6M | −$2.8M | −$4.2M | −$2.2M | −$3.5M | −$2.1M | −$4.1M | −$5.3M | −$5.4M | −$8.0M | −$6.5M | −$7.0M |
| EBITDAderived | −$2.2M | −$2.1M | −$3.2M | −$2.5M | −$2.8M | — | — | — | — | — | — | — | — | — | — |
| Net income | −$2.4M | −$11.7M | −$3.2M | $8.3M | −$3.5M | −$4.6M | −$2.7M | −$3.0M | −$2.5M | −$4.5M | −$5.6M | −$5.8M | −$8.2M | −$6.4M | −$7.0M |
| Basic EPSper diluted share | -$0.04 | -$0.22 | -$0.07 | $0.20 | -$0.10 | -$0.16 | -$0.10 | -$0.12 | -$0.10 | -$0.20 | -$0.27 | -$0.31 | -$0.48 | -$0.48 | -$0.61 |
| Diluted EPSper diluted share | -$0.04 | -$0.22 | -$0.07 | $0.20 | -$0.10 | -$0.16 | -$0.10 | -$0.12 | -$0.10 | -$0.20 | -$0.27 | -$0.31 | -$0.48 | -$0.48 | -$0.61 |